When Karen first went in for an MRI because of chronic headaches, cancer wasn’t even on her radar.

The scan found something unusual in her neck. A biopsy confirmed lymphoma. Then doctors ordered additional imaging to see whether the lymphoma had spread. That’s when they found something else. Suspicious spots on her liver.

A second biopsy revealed stage 4 melanoma that had metastasized from a melanoma spot on her back. By the time doctors discovered it, there were at least 20 lesions on her liver.

What followed became a whirlwind of hospital visits, sleepless nights, research, immunotherapy, supplements, difficult conversations with doctors, and a determination to leave no stone unturned.

Recently, Karen and her husband Jeff shared their experience publicly in a video interview discussing the path they took, including conventional treatment, repurposed medications like ivermectin and fenbendazole, supplements, cannabis products, prayer, and integrative support resources.

Their story has started gaining attention because, according to the interview, Karen’s follow-up PET scan just three months later reportedly showed no remaining melanoma lesions on her liver.

“I Wanted Every Option Available”

Karen’s oncologists recommended immunotherapy immediately.

She underwent treatment using two immunotherapy drugs after having a port installed. According to the interview, she completed 11 total treatments.

At the same time, Jeff says they began researching additional approaches outside standard oncology protocols.

“We started immediately doing fenbendazole, ivermectin,” Jeff explained in the interview, referencing the Joe Tippens protocol.

Jeff, a registered nurse, described spending countless nights researching supplements, alternative therapies, cannabis products, and patient stories while trying to support his wife through two separate cancer diagnoses happening at once.

He repeatedly emphasized one thing throughout the conversation. They were not rejecting conventional medicine.

They wanted more than one strategy.

“I wanted every option available,” he said.

That line probably resonates with many cancer patients and families.

Because when people hear “watch and wait,” “there’s nothing else,” or “just trust the process,” it can leave them feeling powerless. Especially when the disease feels urgent.

The Growing Interest in Repurposed Drugs

Over the past several years, drugs like ivermectin and fenbendazole have become increasingly discussed in alternative cancer communities online.

Supporters point to laboratory studies, anecdotal reports, and patient stories suggesting these medications may affect cancer pathways, inflammation, metabolism, or immune response. Critics argue the evidence remains limited, incomplete, or largely preclinical.

That tension showed up throughout Karen and Jeff’s interview.

Jeff openly acknowledged their oncologists were uncomfortable with some of the protocols they pursued alongside immunotherapy. One doctor, according to the interview, warned Karen she likely had six months to live and criticized their use of alternative therapies.

Still, they moved forward.

Not recklessly, at least in their minds. Intentionally.

Jeff repeatedly says they viewed their approach as complementary rather than either-or. He believes the combination of therapies, supplements, lifestyle changes, and immunotherapy all worked together.

That distinction matters.

A lot of patients exploring integrative or alternative approaches are not necessarily abandoning oncology. Many are trying to combine conventional care with additional therapies they believe could support the body during treatment.

Immunotherapy Likely Played a Major Role

One thing worth stating clearly is this.

Immunotherapy has changed outcomes for some advanced melanoma patients in ways that would have sounded almost impossible twenty years ago.

Drugs like Opdivo (nivolumab) and Yervoy (ipilimumab) have produced long-term remissions in some stage 4 melanoma cases. Karen’s rapid response timeline aligns with what oncologists sometimes see in strong immunotherapy responders.

Even Jeff acknowledged throughout the interview that the conventional treatments appeared to be working.

That’s important context because stories involving alternative therapies can quickly become oversimplified online.

There’s a difference between saying:

“Here’s what this couple chose to do.”

…and claiming:

“This protocol cures cancer.”

Those are not the same thing.

Karen and Jeff themselves repeatedly avoided making definitive claims. In fact, Jeff directly stated:

“I can’t say definitively 100% that it was responsible for everything that we see here today.”

That honesty gives the conversation more credibility, not less.

The Emotional Side of Cancer Nobody Talks About Enough

One of the strongest parts of the interview had nothing to do with supplements or drugs.

It was the exhaustion.

The fear.

The desperation of trying to make the right decisions while watching someone you love fight for their life.

Jeff described staying up night after night researching treatments, printing studies, organizing notebooks, tracking lab work, and trying to make sense of endless information.

Karen talked about chemo brain, fatigue, itching, digestive issues, and the emotional weight of the process itself.

That part often gets lost online.

People sometimes discuss cancer protocols like they’re comparing workout plans or productivity apps.

But this is life-and-death decision making happening under enormous pressure.

Families are scared. Patients are scared. Doctors are trying to balance evidence, liability, risk, and outcomes. Everyone is operating inside uncertainty.

“It’s Your Life. It’s Your Body.”

Toward the end of the interview, Jeff made a statement that reflects a growing mindset among many patients navigating serious illness.

“It’s your life. It’s your body.”

Whether people agree with every decision they made or not, that sentence captures something important happening in healthcare right now.

Patients are asking more questions.

They are researching clinical trials, integrative therapies, nutrition, metabolic health, supplements, repurposed medications, and lifestyle interventions. They are comparing experiences online. They are trying to become active participants in their care instead of passive observers.

Sometimes that leads people toward good information.

Sometimes toward questionable information.

Usually, it’s a mix of both, which is why discernment matters so much.

Why Stories Like This Matter

At Journey to Wellness, we believe stories matter because they expand conversations.

Not every therapy works for every patient. Not every anecdote becomes scientific proof. Not every experimental or alternative approach will hold up under rigorous research.

But patient experiences still deserve thoughtful discussion.

Especially when they raise important questions about integrative care, patient autonomy, emerging therapies, hope, and the need for individualized approaches to cancer treatment.

Karen’s story is not presented here as medical advice or a guaranteed outcome.

It’s one family’s account of what they chose to pursue during an aggressive cancer battle. A story involving immunotherapy, extensive research, supplements, repurposed medications, prayer, community support, and persistence.

And for many readers walking through cancer themselves, sometimes hearing that someone kept fighting matters more than anything else.

Watch the full interview here: From Stage 4 to Clear Scans in 90 Days

The post From Stage 4 Melanoma to Clear Scans in 90 Days first appeared on Journey to Wellness.

When someone with stage 4 pancreatic cancer says their tumors shrank by more than 70%, people pay attention.

That’s exactly what happened when former U.S. Senator Ben Sasse shared details about his response to an experimental drug called daraxonrasib. According to recent reports, Sasse entered a clinical trial after being diagnosed with metastatic pancreatic cancer that had already spread to other organs, including his liver and lungs. Doctors initially gave him only months to live.

Now, after several months on the drug, he says his tumor burden has dropped dramatically.

That doesn’t mean pancreatic cancer suddenly has a cure. Not even close. But stories like this matter because they show something many patients and families already believe deep down. Cancer research is moving fast. Faster than most people realize.

And for people facing diagnoses with limited standard treatment options, experimental therapies often become more than a headline. They become a source of hope.

What Is Daraxonrasib?

Daraxonrasib is an experimental targeted therapy being developed by Revolution Medicines. The drug is designed to target KRAS mutations, genetic alterations that play a major role in many cancers, especially pancreatic cancer.

KRAS mutations are notoriously difficult to treat. For years, researchers referred to them as “undruggable.” That phrase has started disappearing lately.

Daraxonrasib works by interfering with mutated KRAS proteins that help cancer cells grow and spread uncontrollably. Early clinical trial data suggest the drug may significantly extend survival in some pancreatic cancer patients who have already gone through chemotherapy.

Some reports from recent Phase 3 trial data showed median survival reaching 13.2 months compared to 6.7 months with chemotherapy alone.

That may not sound dramatic to someone outside the cancer world. But pancreatic cancer is one of the deadliest cancers known. Even modest gains matter. Doubling survival time gets attention in oncology circles.

Why Pancreatic Cancer Is So Difficult

Pancreatic cancer often grows quietly.

Symptoms tend to appear late. By the time many patients are diagnosed, the disease has already spread beyond the pancreas. That’s one reason survival rates remain so low compared to many other cancers.

Researchers continue exploring new approaches, including:

• Targeted therapies
• Immunotherapy
• Personalized cancer vaccines
• Metabolic therapies
• Combination treatment strategies
• KRAS inhibitors like daraxonrasib

Recently, experimental pancreatic cancer vaccines targeting KRAS mutations have also shown encouraging early results in some patients.

You can feel the momentum building. Not just in one lab or one company. Across multiple areas of research.

The Part Many Headlines Leave Out

Sasse has also been very open about the side effects.

In interviews, he described severe skin reactions, bleeding, fatigue, and painful complications from the drug. He even referred to it as a “nasty drug.”

That’s important context.

Experimental therapies can produce remarkable responses in some patients. They can also come with serious risks, unknowns, and difficult tradeoffs. Clinical trials exist partly because researchers are still learning who responds best, how long responses last, and what side effects patients may face.

That’s why stories like this should be approached with both hope and realism.

Not hype. Not despair either.

Just honest curiosity about where cancer treatment may be heading.

Why Patients Are Paying Attention

For many families dealing with pancreatic cancer, the standard roadmap can feel painfully short.

So when patients hear about therapies that target specific mutations, personalized vaccines, or unexpected tumor regression, they start asking questions. They begin researching clinical trials. They look into precision medicine. They wonder whether their tumor has a KRAS mutation. They ask about genomic testing.

Honestly, that shift may be one of the biggest developments in modern cancer care.

Patients are becoming more informed. More engaged. More willing to explore emerging options alongside conventional treatment.

And physicians are increasingly using genetic profiling to guide treatment decisions instead of relying only on cancer location or stage.

A Reminder Worth Holding Onto

No single story proves a treatment works for everyone.

But individual cases still matter.

They remind people that research is ongoing. That outcomes are not always predictable. That medicine keeps evolving.

Five years ago, many people had never heard of KRAS-targeted therapies. Now some researchers believe this category of drugs could open an entirely new chapter in pancreatic cancer treatment.

For patients facing difficult diagnoses, even the possibility of another option matters.

And sometimes, that’s enough to keep people searching, asking questions, and refusing to give up.

Source Article: Fox News report on Ben Sasse and daraxonrasib

The post Ben Sasse’s Pancreatic Cancer Response Is Giving New Hope to Patients Watching Experimental Treatments Closely first appeared on Journey to Wellness.

For many, this might sound surprising.

Vitamin C? The same thing found in oranges?

But the conversation becomes more interesting when you look a little closer.

What the Research Suggests

According to the study referenced in the article, researchers are exploring how high-dose intravenous (IV) vitamin C behaves very differently in the body compared to what we get from food or standard supplements.

At high concentrations — levels only achievable through IV delivery — vitamin C may act less like a typical antioxidant and more like a pro-oxidant, meaning it can help generate hydrogen peroxide in the tumor environment.

Why does that matter?

Because cancer cells are often more vulnerable to oxidative stress than healthy cells. The idea is that high-dose vitamin C could selectively stress or damage cancer cells while leaving normal cells relatively unharmed.

In the study, researchers observed that this approach may:

• Increase sensitivity of tumor cells to treatment
• Slow tumor progression in certain models
• Work alongside standard therapies rather than replacing them

This is especially relevant for glioblastoma, one of the most aggressive and difficult-to-treat brain cancers.

Not a Replacement — But a Potential Addition

One of the most important takeaways from both the study and the Fox News coverage is this:

This is not being presented as a standalone cure.

Instead, researchers are looking at vitamin C as a complementary therapy — something that could potentially enhance the effectiveness of existing treatments like chemotherapy and radiation.

That distinction matters.

Because in cancer care, the conversation isn’t always about choosing one path over another. Sometimes, it’s about asking:

What can work together?

Why This Matters

For patients and families facing aggressive cancers, options can feel limited. Standard treatments may slow progression, but outcomes can still be uncertain.

That’s why research like this is important.

It opens the door to new questions:

• Can metabolic therapies support conventional treatment?
• Can relatively low-toxicity compounds improve outcomes?
• Can we make existing treatments work better, not just stronger?

These are the kinds of questions researchers are beginning to explore more seriously.

A Growing Area of Interest

High-dose vitamin C isn’t a brand-new idea. It has been studied on and off for decades, often with mixed or inconclusive results — largely because earlier studies used oral dosing, which does not achieve the same blood concentrations as IV therapy.

Now, with better understanding of cancer metabolism and improved study design, researchers are revisiting it with a fresh perspective.

And while the science is still evolving, the renewed interest signals something important:

There is a growing willingness to explore integrative approaches that work alongside traditional oncology.

What to Take Away

This study doesn’t change the standard of care overnight.

But it does add to a growing body of research suggesting that:

• Cancer may be influenced by metabolic and biochemical factors
• Certain therapies could complement existing treatments
• There may be more than one way to approach the problem

For patients, this reinforces the importance of staying informed, asking questions, and working closely with qualified medical professionals when exploring any treatment path.

Disclaimer:

This article is for educational purposes only. Journey to Wellness does not provide medical advice or recommend any specific treatment. High-dose vitamin C therapy should only be considered under the supervision of a licensed healthcare professional.

The post Could High-Dose Vitamin C Play a Role in Brain Cancer Treatment? first appeared on Journey to Wellness.

The death of James Van Der Beek at 48 is heartbreaking.

When someone so visible, so full of life, is taken by cancer, it hits differently. It shakes people. It raises questions. It makes us look at the system and ask: Are we doing everything we can?

Colon cancer has been rising in younger adults for years. That’s what the data says. Screening guidelines were lowered to age 45 because the trend became impossible to ignore.

But moments like this don’t just raise awareness about screening. They also reignite a deeper conversation about treatment.

Many families quietly wonder:

• Why do some cancers respond well to treatment… and others don’t?
• Why does the same chemotherapy regimen get used for decades?
• Why do some people experience remission, while others run out of options?

These are normal, human questions.

It’s important to say this clearly:

Conventional cancer treatments — surgery, chemotherapy, radiation, targeted drugs — have saved millions of lives. They are not the enemy. They are powerful tools.

But cancer is not one disease. It is complex. Adaptive. Metabolic. Individual.

That complexity is why research continues to evolve.

In recent years, more doctors and researchers have begun exploring additional approaches alongside traditional care:

• Metabolic therapies
• Repurposed medications
• Immunotherapy combinations
• Nutritional and orthomolecular support
• Lifestyle interventions
• Mitochondrial research

These conversations are not about rejecting oncology. They’re about expanding it.

Some physicians have shared clinical observations of patients stabilizing cancers using integrative approaches that include repurposed medications. Others caution that more clinical trials are needed. Both perspectives deserve space in the discussion.

The goal isn’t rebellion.

The goal is better outcomes.

When someone says, “Be open to other options,” that doesn’t mean “abandon your oncologist.” It means ask questions. It means research responsibly. It means explore what might complement standard care — especially when options feel limited.

James Van Der Beek’s passing is not a political statement about treatment. It’s a reminder that cancer is still unpredictable. It’s a reminder that we need early detection, better prevention, and continued innovation in how we approach this disease.

And it’s a reminder that hope should never be confined to one lane.

If you or someone you love is facing cancer:

• Get screened early.
• Seek expert medical guidance.
• Stay informed.
• Ask about integrative approaches.
• Advocate for yourself.

There is room for conventional medicine.

There is room for emerging science.

There is room for thoughtful exploration.

The conversation doesn’t have to be either/or.

It can be both.

Disclaimer:

This article is for educational purposes only. Journey to Wellness does not provide medical advice or recommend any specific treatment. Always consult a licensed healthcare professional before making decisions regarding cancer care.

The post When a Public Loss Sparks a Bigger Conversation About Cancer Care first appeared on Journey to Wellness.

What the Researchers Studied

The researchers tested fenbendazole in two main ways:

• On breast cancer cells in the lab
• In mice implanted with breast cancer tumors

Their goal was not to prove a cure, but to understand how fenbendazole interacts with cancer cells and whether it shows anti-cancer activity under controlled conditions.

What They Found

1. Tumor growth slowed in mice
   Mice treated with fenbendazole developed smaller tumors compared to untreated mice. Tumor growth was noticeably slower over time.
2. Cancer cells were pushed into a specific type of cell death
   Fenbendazole triggered a process called pyroptosis. Unlike quiet cell death (where cells simply shut down), pyroptosis causes cancer cells to swell, rupture, and self-destruct in a way that can alert the immune system.
3. In simple terms, the cancer cells didn’t just stop growing — they were forced into a violent shutdown they couldn’t easily escape.
4. Cancer’s energy supply was disrupted
   Cancer cells depend heavily on sugar for fuel. The study showed that fenbendazole reduced activity of a key enzyme (HK2) involved in glycolysis, the process cancer cells use to rapidly generate energy.
5. By interfering with this energy system, fenbendazole made it harder for cancer cells to survive and multiply.
6. Limited toxicity was observed in mice
   Compared to traditional chemotherapy used as a control in the study, fenbendazole did not cause obvious liver or kidney damage in the mice. Body weight and organ tissue appeared largely unaffected during the study period.

What This Means — and What It Doesn’t

This study helps researchers better understand how fenbendazole may affect cancer cells at a metabolic level. It supports the idea that disrupting cancer’s energy systems and survival mechanisms is an area worth further investigation.

At the same time:

• This was not a human trial
• The findings do not prove fenbendazole is a cancer treatment
• Dosage, safety, and effectiveness in humans remain unknown
• Clinical trials would be required before any medical use could be considered

Why This Research Matters

Much of modern cancer research is shifting toward metabolic and systems-based approaches—looking beyond tumors alone and examining how cancer cells fuel themselves, resist treatment, and return after therapy.

This study contributes to that growing body of research by showing that fenbendazole:

• Interferes with cancer metabolism
• Activates a hard-to-avoid form of cancer cell death
• Demonstrates these effects in pre-clinical models without obvious toxicity

It doesn’t offer answers yet, but it adds important data to an ongoing scientific conversation.

Disclaimer:
This article is for educational and informational purposes only. Journey to Wellness does not provide medical advice or recommend any treatment. Always consult a qualified healthcare professional before making decisions related to cancer care, medications, or supplements.

The post Fenbendazole and Breast Cancer: What a New Study Found first appeared on Journey to Wellness.

What if cancer treatment could target not just tumors, but the fuel source that keeps them alive? That’s the idea Dr. Pete Sulack discusses in a recent video (watch it here) after a new study published in the Journal of Orthomolecular Medicine on September 19, 2024.

According to the study, researchers introduced the first peer-reviewed protocol combining three repurposed drugs — ivermectin, mebendazole, and fenbendazole — used together with orthomolecular support and lifestyle therapies. The goal: disrupt the mitochondria within cancer stem cells, which fuel cancer’s ability to grow, resist treatment, and return after remission.

In the video, Dr. Sulack explains it this way:

“This protocol doesn’t just throw medicine at the tumor. It targets the mitochondria stem cell connection — the actual engine room of cancer.”

He describes this as more than a treatment strategy — it’s a framework for thinking differently about cancer:

“Repurposed drugs, orthomolecular support, lifestyle therapies. It’s not a silver bullet. It’s not a replacement for care, but a blueprint for hope.”

While he stresses that the science is still early and that clinical trials are needed, Dr. Sulack views this as a promising step forward:

“The science is early. Clinical trials still need to be done. But make no mistake — this is a major step forward in how we think about cancer.”

Dr. Sulack, who openly shares his own stage 4 brain cancer recovery journey, closes his message with gratitude and compassion:

“If you want my entire healing protocol, the one that I used to overcome stage 4 brain cancer, simply comment ‘protocol’ below. I’ll gladly send it to you for free. Thank you for joining me on this journey. I love you all so much.”

At Journey to Wellness, we value voices like Dr. Sulack’s — those willing to explore new scientific ideas while keeping faith and empathy at the center of the conversation. His emphasis on metabolic health, lifestyle choices, and repurposed compounds reflects a growing movement toward integrative education in cancer care.

Still, as Dr. Sulack himself notes, this approach does not replace medical treatment or clinical supervision. It’s a conversation starter—a way of asking how we might one day treat the root of cancer, not just its symptoms.

Disclaimer: This article is for informational and educational purposes only. Journey to Wellness does not provide medical advice or endorse any specific treatment. Always consult a licensed healthcare professional before starting, stopping, or modifying any therapy or supplement regimen.

The post Dr. Pete Sulack on Repurposed Drugs and Hope for the Future of Cancer Care first appeared on Journey to Wellness.

Recently, two community members shared updates that lifted the spirits of thousands following along.

One man wrote about his fight with stage 4 prostate cancer. When diagnosed, his PSA level was 140. Within three months, after adjusting his diet and beginning the Tippens protocol, his results began to change.

“I started Joe’s protocol immediately. I changed my diet, cut out a huge amount of processed foods, and cut sugar out completely. I got the testosterone blocker 30 days ago and I’m proud to say my PSA has dropped to 28.”

He credits consistency, lifestyle changes, and the encouragement of his wife for keeping him motivated every day:

“A huge shout out to my beautiful wife who keeps me motivated and moving in the right direction.”

Another community member shared her own update that radiates gratitude and faith.

“So thankful to say my six-month scan came back clear! I was diagnosed with terminal stomach cancer in February 2023 and have now been cancer-free for two years!”

She added words of encouragement for others walking a similar path:

“Whatever you’re going through, keep fighting and stay positive. Pray, pray, pray.”

Every journey looks different. Each diagnosis, body, and treatment plan carries its own story — but hearing from people who continue to hope, adjust, and persevere gives strength to those still in the fight.

At Journey to Wellness, we share these stories not as medical advice, but as real experiences that remind us what resilience can look like. Sometimes it’s a lab result moving in the right direction. Other times, it’s simply the will to get up and try again.

Disclaimer: These are personal testimonials from individuals in the My Cancer Story community. Journey to Wellness shares these for educational and inspirational purposes only and does not offer medical advice or endorse any treatment. Always consult a licensed healthcare professional before starting or changing any medical or supplemental regimen.

The post Courage, Change, and Hope: Two People Share Their Cancer Journeys first appeared on Journey to Wellness.

When a diagnosis feels overwhelming, sometimes hope comes from unexpected places. One family recently shared their remarkable journey after turning to the Joe Tippens protocol.

Seventeen months ago, a woman was diagnosed with stage 4 lung cancer that had spread to her brain. Doctors gave a grim prognosis, and the path forward seemed uncertain. Like so many others, the family began searching for answers beyond conventional treatments.

They decided to try the Tippens protocol, a regimen that has gained attention in patient communities worldwide. With faith, determination, and the support of loved ones, she followed the protocol consistently for over a year.

Recently, after 17 months, her latest scans revealed something extraordinary: she is now 100% cancer free. The metastasis in her brain is gone, and her doctors found no evidence of disease.

Her husband expressed deep gratitude for the prayers and encouragement they received along the way:

“I want to thank all of you for your support every time I had a question. Thank you, thank you for your prayers.”

Their story is not just about remission — it’s about hope, perseverance, and the power of community. For families facing similar battles, it serves as a reminder that sometimes the journey to wellness takes a path less expected.

Disclaimer: This story reflects the personal experience of one family and is shared for educational purposes only. Journey to Wellness and the Sturgeon Family Foundation do not provide medical advice, endorse specific treatments, or guarantee outcomes. Every individual’s situation is unique, and health decisions should always be made in consultation with a qualified medical professional.

The post Stage 4 Lung Cancer to Cancer Free first appeared on Journey to Wellness.

The post Country Legend John Berry Tries Fenbendazole in His Cancer Battle first appeared on Journey to Wellness.

But John couldn’t shake the feeling that the path laid out for him wasn’t his only option. After going through three rounds of CyberKnife radiation to his chest, he declined the rest of the recommended treatments, including chemotherapy and brain radiation.

Then, something shifted.

He stumbled across a YouTube video featuring Joe Tippens, a man whose own cancer recovery journey inspired thousands. John had seen countless cancer “cures” online by then, most of which left him skeptical or overwhelmed. But this one felt different.

He believed it.

And that belief became the beginning of his new chapter.

A Radical Shift

John began following what’s known in the cancer recovery community as “Joe’s Protocol,” a supplement regimen that includes fenbendazole, curcumin, CBD oil, and vitamin E. While many oncologists won’t officially endorse these alternative approaches, John quietly pressed forward with his new plan.

He didn’t share the protocol with his doctors. “They don’t want to know,” he said plainly.

But what he did do, was choose to live.

The first part of his healing, he says, wasn’t a pill or a therapy. It was mindset.

“I wanted to live very badly,” John wrote in his post. “I expected that I was healing, and that each scan would be an improvement.”

Ninety Days Later

Three months into the protocol, he returned for a PET scan.

He considered pausing the protocol for a few days — he’d read that continuing might mask the cancer from detection — but in the end, he stuck with it. He was feeling better than he had in years, and he didn’t want to give any ground back to the cancer.

The results?

He was officially NED — No Evidence of Disease.

The oncologists were stunned.

Just weeks before, they’d told him that his cancer was doubling every month, growing rapidly on a scale of 91 out of 98. Now, they couldn’t find any tumors, nodules, or signs of metastasis. And it didn’t stop there.

After 180 days on the protocol, John still had no signs of cancer.

No tumors.

No nodes.

No fluid.

Just a clean scan and a chance to keep living.

The Power of Belief and Prayer

John is quick to acknowledge that his journey wasn’t just physical, it was spiritual. He credits much of his strength and healing to prayer, a supportive network of “prayer warriors,” and a faith that kept him grounded.

He also recognizes how vital it was to have a positive mindset. “Not everyone wants to live,” he said. “Some want the attention that comes with a terminal illness. I wanted to live.”

What We Can Learn

This story is one of many emerging from people who are choosing to explore options outside the conventional medical box. While traditional cancer treatments like chemo, radiation, and surgery are the mainstream standard, they aren’t the only roads being walked.

John’s journey is not medical advice. It’s a story of personal choice, faith, and curiosity. A man who felt led to try something different and saw astonishing results.

His scans were real.

His recovery was witnessed.

And his gratitude is palpable.

Our mission at Journey to Wellness is to share stories like John’s so others can explore, research, and decide for themselves what paths might bring healing. We don’t sell products. We don’t prescribe treatments. We simply bring voices to light — voices that might otherwise go unheard.

Your journey is your own. But you’re not alone in walking it.

The post From Stage 4 Lung Cancer to No Evidence of Disease first appeared on Journey to Wellness.